- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
New LCD monitors broaden palettes of color and gray-scale tones
Eizo Nanao Technologies is showing a pair of new multipurpose 3-megapixel liquid crystal display monitors at the RSNA meeting. The monitors, released earlier this fall, are now available for sale worldwide.
Eizo Nanao Technologies is showing a pair of new multipurpose 3-megapixel liquid crystal display monitors at the RSNA meeting. The monitors, released earlier this fall, are now available for sale worldwide.
The monochrome RadiForce G33 is designed for PACS, chest radiography, CT, MRI, and angiography. It produces a palette of 8161 gray-scale tones - 4096, or 12 bits, of them can be displayed simultaneously.
The unit incorporates Eizo's aperture modulation technology, which intensifies the differences between black and white tones by enabling a different area ratio for each subpixel. The G33 has a built-in sensor that allows precise remote calibration. Its Digital Uniformity Equalizer unifies the luminance of the backlight.
The color and monochrome RadiForce R31 for CT, MRI, PET, and 3D rendering has a 10-bit color input compatibility that can display up to a trillion colors simultaneously. The R31's image rotation technology permits users to switch easily from landscape to portrait mode. It also eliminates the need for special software for gray-scale rendering without banding or color seepage.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
